Navigation Links
JumpStart Invests $250,000 in OrthoData, Inc.

CLEVELAND, March 28, 2013 /PRNewswire/ -- OrthoData, Inc. (, an Akron-based medical device company developing a novel diagnostic system for spine surgeons, has received a $250,000 investment commitment from Cleveland-based nonprofit venture development organization JumpStart Inc. ( OrthoData's breakthrough implantable microelectronic spine fusion sensor, known as the IntelliRod™ system, enables surgeons to assess the success of spinal fusion procedures without exploratory surgery.

"Up to 30 percent of post-operative patients experience continuing pain," says OrthoData's President and CEO, Ric Navarro . Determining the cause of this pain—which can occur due to incomplete fusion of the vertebrae—often requires further surgery, slowing patients' recovery time. "OrthoData's IntelliRod™ system allows surgeons to track the outcome of the initial fusion surgery without invasive procedures and with less radiation exposure to the patient," Navarro says.

OrthoData's diagnostic system is more affordable than other methods used to assess post-operative progress, such as CT scans. In addition, the IntelliRod system is more quantifiable than imaging, as it provides objective postoperative measurement of the extent of spinal fusion.

"OrthoData's technology has the potential to transform the postoperative management of spine implant patients," says Michael Lang , JumpStart Venture Partner. "By providing early indication if the spine is or is not fusing, surgeons can intervene with alternative therapies sooner. In addition, OrthoData's solution can allow the patient to return to normal activities more quickly. The net effect is both better outcomes and reduced costs." OrthoData's solution could greatly benefit high-risk spinal fusion patients including diabetics, smokers and the elderly.

OrthoData plans to use the investment to complete prototype development and conduct relevant animal studies.

ORTHODATA, INC. OrthoData, Inc. is an Akron, Ohio-based medical device company developing the IntelliRod™ system, a breakthrough implantable spine fusion sensor. This innovative diagnostic system will enable spine surgeons to accurately assess the success of spinal fusion and eliminate the need for unnecessary exploratory surgery while accelerating patients' post-surgery recovery.

JUMPSTART INC. JumpStart accelerates the successes of diverse entrepreneurs, their companies and the ecosystems supporting them. The Cleveland-based nonprofit has given intensive business assistance to more than 440 entrepreneurial clients and invested in 71 early stage Northeast Ohio companies since 2004. For more information on the nonprofit development organization, visit and follow @JumpStartInc on Twitter.

TO SHARE ON FACEBOOK, LINKEDIN OR TWITTER: Meet @jumpstartinc 71st portfolio co. OrthoData developing revolutionary implantable spine fusion sensor: #Akron

SOURCE JumpStart Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Brookside Mezzanine Partners Invests in Longhorn Health Solutions
2. Australian Government Invests in Detection and Management of Blinding Eye Disease and Diabetes Through Intelligent High Resolution Retinal Camera Development by Vision CRC
3. Foundation Venture Capital Group Invests In Start-Up Working to Reduce Side Effects of Parkinsons Treatment
4. MinuteClinic Recognizes National Nurse Practitioner Week and Invests in the Education and Advancement of Clinicians Across the U.S.
5. West Health Investment Fund invests in GlySens and RxAnte
6. Australian Business Mogul Bruce Mathieson Invests in iSonea
7. Golden Seeds Invests In DxUpClose, Disruptive Technology That Performs An Antibiotic Sensitivity Test At The Patients Bedside In Less Than An Hour
8. Sentry BioPharma Services Invests in Global Clinical Supply Services with -45C Freezer Expansion
Post Your Comments:
(Date:11/25/2015)... SHENZHEN, China , Nov. 25, ... or the "Company") (NYSE: MR ... marketer of medical devices worldwide, today ... 2015 annual general meeting of shareholders ... 1 11/F, Grand Century, 193 Prince Edward ...
(Date:11/25/2015)... --> --> ... für das Patent über eine neue Hepatitis-B-Behandlung, welches sie ... an Enyo Pharma vergeben haben. Im Rahmen ... und von Edelris gemeinsam mit seinen Partnern Inserm und ... HBV identifiziert, und es wurden neue Inhaltsstoffe entdeckt, die ...
(Date:11/24/2015)... Nov. 24, 2015  Thanks to a donor with ... Mary,s Medical Center,s Sister Diane Grassilli Center for Women,s ... in San Francisco . ... stepped forward with a gift of $617,320 that allowed ... Mammography with Tomosynthesis and Whole Breast Ultrasound. Tomosynthesis, three-dimensional ...
Breaking Medicine Technology:
(Date:11/25/2015)... D.C. (PRWEB) , ... November 25, 2015 , ... Today, ... fatalities on our nation’s roadways has dropped below 10,000 for the first time since ... 10,076 in 2013. , According to data released by the National Highway Traffic Safety ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing ... this disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... announced that it has undertaken significant expansion of its current state of the ... is part of PharmaTech’s strategy to increase its manufacturing capacity as well as ...
(Date:11/25/2015)... ... , ... Many people know of the common symptoms of low thyroid hormone ... But many people who find their cholesterol levels and weight are creeping up are ... if they don’t have any of the other symptoms. , Thyroid hormone plays a ...
(Date:11/25/2015)... ... , ... Since its launch in 2012, the Regenestem brand ... therapies to patients with chronic degenerative medical conditions. Now, the U.S. Patent and ... , Organizations are required to hold a registered trademark in order to make ...
Breaking Medicine News(10 mins):